Castle Biosciences, Inc.
$33.50
-0.76 (-2.22%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +25.0%
- 3 Months
- +58.9%
- YTD
- -13.9%
- 1 Year
- +50.4%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 57.2%
- Largest decline max drawdown, since Aug 2025
- -57.8%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.00
Own CSTL?
See how CSTL contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.